发明名称 |
GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF |
摘要 |
<p>Disclosed is an agent for preventing the expression of an inflammatory cytokine in a joint and/or the destruction of a joint (e.g., the destruction of an articular cartilage) and/or a pain in a bone/joint disease, which comprises a substance capable of inhibiting the expression or activity of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence depicted in SEQ ID NO:2. Also disclosed is a method for the screening of a substance capable of controlling the expression of an inflammatory cytokine in a joint and/or the destruction of a joint (e.g., the destruction of an articular cartilage) and/or a pain in a bone/joint disease, which is characterized by using the protein or a partial peptide thereof. Further disclosed is a method for the diagnosis of a genetic sensitivity to a bone/joint disease, which comprises detecting a polymorphism in a nucleotide represented by Nucleotide No. 24007 in a partial nucleotide sequence of human EDG2 gene depicted in SEQ ID No:3.</p> |
申请公布号 |
WO2008153072(A1) |
申请公布日期 |
2008.12.18 |
申请号 |
WO2008JP60700 |
申请日期 |
2008.06.11 |
申请人 |
RIKEN;TAKEDA PHARMACEUTICAL COMPANY LIMITED;IKEGAWA, SHIRO;MOTOTANI, HIDEYUKI |
发明人 |
IKEGAWA, SHIRO;MOTOTANI, HIDEYUKI |
分类号 |
A61K39/395;A61K31/7088;A61K38/00;A61K48/00;A61P19/00;A61P19/02;A61P19/10;A61P25/02;A61P29/00;A61P35/00;A61P43/00;C07K16/28;C12Q1/02;C12Q1/68;G01N33/15;G01N33/50 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|